2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Thursday, June 8, 2017

1:15pm-2:45pm: MitoQ and Reduced Glutathione Protects Against Dopamine Induced Brain Mitochondrial Electron Transport Chain Inhibition During Extended In Vitro Incubation: Involvement of Free Radicals and Quinone Products

A. MAITI (Bengaluru, India)

Clinical Trials and Therapy in Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Modulation of executive motor network after neurofeedback training in Parkinson’s disease

N. Smulders, D. Mehler, L. Subramanian, D. Linden, J. Whittaker (Cardiff, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Morphometric changes in Parkinson’s disease manifesting freezing of gait

S. Pietracupa, A. Suppa, N. Upadhyay, A. Zampogna, F. Di Biasio, G. Grillea, N. Modugno, G. Fabbrini, A. Berardelli, P. Pantano (Pozzilli, Italy)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Motor and Body Composition Variables by Parkinson’s Disease Staging

L. LEANDRO, C. MOREIRA, H. TEIVE (Curitiba, Brazil)

Clinical Trials and Therapy in Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Motor effects and safety of IPX203, an investigational extended-release formulation of carbidopa-levodopa, in advanced Parkinson’s disease: A single-dose study

M. Stacy, V. Biton, J. Aldred, A. Ellenbogen, R. Rubens, N. Modi, A. Mittur, S. Khanna, S. Gupta (Durham, NC, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Motor Heterogeneity in Parkinson’s Disease: A Bayesian Perspective

A. Johnson, A. Loftus, N. Gasson, B. Lawrence, M. Thomas, R. Bucks (Perth, Australia)

Other · Exhibit Hall C

1:15pm-2:45pm: Motor stress elicits dystonia-like movements in a pharmacological mouse model for Rapid-Onset Dystonia-Parkinsonism (DYT12)

L. Rauschenberger, J. Volkmann, C.W. Ip (Wuerzburg, Germany)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Movement disorder specialists’ determination of eligibility for device aided treatment in advanced Parkinson’s disease: Results from the OBSERVE-PD study

A. Fasano, K. Seppi, V.SC. Fung, J.C. Parra, L. Bergmann, A. Yegin, K. Sail, Y. Jalundhwala, K. Onuk (Toronto, ON, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Movement Disorders in Demyelinating Diseases: a retrospective review from a tertiary academic center.

G. Suarez-Cedeno, M. Raja (Houston, TX, USA)

Other · Exhibit Hall C

1:15pm-2:45pm: Moxibustion for Parkinson’s disease: a systematic review of randomized controlled trials

T.-H. Kim, S. Kwon, W.-S. Jung, S.-K. Moon, C.-N. Ko, S.-Y. Cho, C.-Y. Jun, S.-H. Lee, K.-H. Cho (Seoul, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C